Journals / Online Türk Sağlık Bilimleri Dergisi / 2017 / Cilt: 2 - Sayı: 4

Examination of antibacterial properties of three thiazolidine-4-carboxylic acid derivatives against Pseudomonas, Acinetobacter, Staphylococcus aureus, and Escherichia coli

Üç Thiazolidine-4-Karboksilik Asit Türevinin Pseudomonas, Acinetobacter, Staphylococcus Aureus ve Escherichia Coli Bakterilerine Karşı Antibakteriyel Özelliklerinin İncelenmesi

Pages
1–10
Publication Date
2017-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But it is clear that further research and in-vitro activity tests of these three compounds should be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Treatment of multi-drug resistant bacteria is a growing problem for global public health.
📊
Key Findings & Data:It is known that Thiazolidine-4-carboxylic acids (TCA) are able to inhibit bacterial growth by mimicking various essential functions of naturally occurring amino acids.
💡
Conclusion & Impact:But it is clear that further research and in-vitro activity tests of these three compounds should be performed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anti-bakteriyel maddeler · ilaç direnci · sistein

Abstract

Treatment of multi-drug resistant bacteria is a growing problem for global public health. We need new drugs to keep up with resistant. It is known that Thiazolidine-4-carboxylic acids (TCA) are able to inhibit bacterial growth by mimicking various essential functions of naturally occurring amino acids. Therefore, we aimed to synthesis three TCA derivatives, two of them are novel, and investigated their antibacterial activities on multi-drug resistant (MDR) bacteria. Compounds (1a-c) were synthesized from L-Cysteine hydrochloride and dihydroxybenzaldehyde derivatives and their in vitro activities against multi-drug resistant bacteria were assayed by the Kirby-Bauer method according to CLSI criteria. 1a-c exhibited significant antibacterial effect against Gram-positive bacteria such as S. aureus and Gram-negative bacteria such as Pseudomanas, Acinetobacter, and Escherichia coli superior to current antibiotics. Here, new potential antibacterial agents, which can be easily synthesized in high yield under mild condition, have been reported. But it is clear that further research and in-vitro activity tests of these three compounds should be performed.

Özet

Çok ilaca dirençli bakterilerin tedavisi, halk sağlığı için artan bir küresel sorundur. Bu dirence ayak uydurabilmek için yeni ilaç aktif maddelerine ihtiyaç duyulmaktadır. Tiazolidin-4-karboksilik asitlerin (TCA) doğal olarak oluşan amino asitlerin çeşitli esas işlevlerini taklit ederek bakteri gelişimini engelleyebildiği bilinmektedir. Bu nedenle, ikisi yeni olan üç TCA türevinin sentezlenmesi amaçlanmış ve antibakteriyel aktiviteleri çok ilaca dirençli (MDR) bakteriler üzerinde araştırılmıştır. Bileşikler (la-c), L-Sistein hidroklorür ve dihidroksibenzaldehit türevlerinden sentezlendi ve çoklu ilaç dirençli bakterilere karşı in vitro aktiviteleri CLSI kriterlerine göre Kirby-Bauer yöntemi ile denendi. 1a-c, mevcut antibiyotiklere kıyasla S. aureus gibi Gram pozitif bakterilere ve Pseudomanas, Acinetobacter ve Escherichia coli gibi Gram negatif bakterilere karşı önemli antibakteriyel etki sergiledi. Burada, ılıman şartlar altında yüksek verimle kolaylıkla sentezlenebilen yeni potansiyel antibakteriyel maddeler bildirilmiştir. Ancak, bu üç bileşiğin daha ileri araştırmalarının ve in-vitro etkinlik testlerinin yapılması gerektiği açıktır.

🔖

Cite This Article

GENÇ, H., ZENGİN, M., ÖĞÜTLÜ, A., KARABAY, O. (2017). Examination of antibacterial properties of three thiazolidine-4-carboxylic acid derivatives against Pseudomonas, Acinetobacter, Staphylococcus aureus, and Escherichia coli. Online Türk Sağlık Bilimleri Dergisi, Cilt: 2 - Sayı: 4, 1–10. https://ajindex.com/articles/694534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sriramurthy V, Barcan GA, Kwon O. Bisphosphine-catalyzed mixed double-Michael reactions: Asymmetric synthesis of oxazolidines, thiazolidines, and pyrrolidines. J Am Chem Soc 2007; 129:12928-12929
  2. Song ZC, Ma GY, Lv PC, Li HQ, Xiao ZP, Zhu HL. Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents. Eur J Med Chem 2009; 44:3903-3908
  3. Moallem SA, Imenshahidi M, Shahini N, Javan AR, Karimi M, Alibolandi M et al. Synthesis, anti-inflammatory and anti-nociceptive activities and cytotoxic effect of novel thiazolidin-4-ones derivatives as selective cyclooxygenase (COX-2) inhibitors. Iran J of Basic Med Sci 2013; 16:1238-1244
  4. Hutt MP, Antibacterial thiazolidine or thiomorpholine substituted quinolones. US Patent 4,473,568 A, 25 Sep. 1984
  5. Onen-Bayram FE, Durmaz I, Scherman D, Herscovici J, Cetin-Atalay R, A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells. Bioorg Med Chem 2012; 20:5094-5102
  6. Li W, Lu Y, Wang Z, Dalton JT, Miller DD, Synthesis and antiproliferative activity of thiazolidine analogs for melanoma. Bioorg Med Chem Lett 2007; 17:4113-4117
  7. Aiello F, Brizzi A, De Grazia O, Garofalo A, Grande F, Sinicropi, MS et al. An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integrase. Eur J Med Chem 2006; 41:914-917
  8. Ha YM, Park YJ, Lee JY, Park D, Choi YJ, Lee EK et al. Design, synthesis and biological evaluation of 2-(substituted phenyl) thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors. Biochimie 2012; 94:533-540
  9. Unger L, DeMoss RD. Action of a proline analogue, l-thiazolidine-4-carboxylic acid, in Escherichia coli. J Bacteriol 1966; 91:1556–1563
  10. Anderson RJ, Groundwater PW, Todd A, Worsley AJ. Antibacterial Agents: Chemistry, Mode of Action, Mechanisms of Resistance and Clinical Applications, John Wiley and Sons; 2012
  11. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M. Antimicrobial resistance. Is a major threat to public health. BMJ 1998; 317:609-610
  12. Chauhan R, Abraham J. In vitro antimicrobial potential of the lichen Parmotrema sp. extracts against various pathogens. Iran J of Basic Med Sci 2013; 16: 882-885
  13. Flaherty JP, Weinstein RA. Nosocomial Infection Caused by Antibiotic-Resistant Organisms in the Intensive-Care Unit. Infect Control Ho